News
$2m boost to translate cancer research from lab to patient
University of Queensland researchers have received $2 million from the National Health and Medical Research Council to improve understanding of prostate and breast cancer and expedite the translation of research outcomes.
The Development Grants scheme funds early-stage health and medical projects with a clear path to commercialisation and strong potential for intellectual property.
NHMRC Development Grants recipients:
Professor Gregory Monteith – improve a leading therapy for the treatment of advanced and refractory prostate cancer.
Associate Professor David Muller – develop needle-free mRNA vaccines for the protection from and treatment of HER2+ breast cancer.
Topics
Related articles
UQ researcher awarded international anti-doping grant
A University of Queensland researcher has secured a $30,000 research grant through UQ’s partnership with the International Testing Agency (ITA), supporting a project examining medication use and anti-doping processes in elite sport.
3 November 2026
Outstanding UQ educators recognised for excellence in teaching
Emerging academics whose innovative teaching approaches are shaping the next generation of professionals have been recognised in 2026 University of Queensland Awards for Teaching Excellence.
3 November 2026